Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +971 (0) 4 368 1644
  • GDPR
  • Journalists
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +971 (0) 4 368 1644 from 8 AM - 5:30 PM GMT

    • Contact
    • Contact

      +971 (0) 4 368 1644
      from 8 AM - 5:30 PM GMT

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

European Wellness partners with China's provincial government to advance Education in Biological Regenerative Medicine
  • USA - English
  • USA - Polski
  • USA - español
  • Latin America - español
  • Brazil - Português
  • USA - čeština
  • USA - Deutsch
  • USA - Pусский
  • USA - Français
  • USA - slovenčina

Logo

News provided by

European Wellness Biomedical Group

01 Jul, 2021, 00:00 GMT

Share this article

Share toX

Share this article

Share toX

EDENKOBEN, Germany, July 1, 2021 /PRNewswire/ – European Wellness Biomedical Group (European Wellness) through its educational arm, European Wellness Academy (EWA), has signed a Letter of Intent (LOI) with Zhifu People's Government of Yantai City, Shandong Province, China to establish the first International Biological Regenerative Medicine Education Centre in Shandong Province via the Connecting Shandong with Fortune Global 500 & Deepening Shandong – EU Cooperation event.

Continue Reading
Prof. Dr. Mike Chan in the live international signing session involving Fortune Global 500.
Prof. Dr. Mike Chan in the live international signing session involving Fortune Global 500.

In a live digital signing session, the two parties agreed on a joint venture that will see a total investment of RMB 100 million (USD 15.4 million) for the building and launching of a world-class biological regenerative medicine education centre for disease management and aesthetics in Yantai City, China.

The multimillion-dollar project comes at a time where biological regenerative medicine has rapidly emerged as an area of interest, globally and in China, amid rising health concerns. The collaboration will supplement efforts to improve resources, training, and knowledge in integrative regenerative medicine within the region to meet current and future demand.

EWA was represented by its Group Chairman, Prof. Dr. Mike Chan, in the signing session hosted by the Shandong Provincial Party Committee and overseen by the Municipal Government Office, together with representatives from Fortune Global 500 companies including the Chairman of Continental's Executive Board, Pirelli's Executive Vice Chairman and CEO, and Saint-Gobain's Senior Vice President and Asia Pacific CEO.

"The global burden of chronic diseases is rapidly rising. Regenerative medicine is the future and the present. To cope with the needs of the future, educational trainings are crucial; the number of professional high-end medical and wellness practitioners must be able to meet the demands that are to come," said Prof. Dr. Mike Chan, Head of the Scientific Committee for Regenerative Medicine of the European Society of Preventative, Regenerative and Anti-Aging Medicine (ESAAM).

European Wellness Academy

Located in Germany, Switzerland, Greece and Malaysia, EWA is a CPD authorised body with a premium training and development wing that revolves around cutting-edge Bio-Regenerative Medicine modalities for practitioners and researchers. The Academy has extensive years of combined clinical experience and a core academic team comprising of qualified MDs and scientists with numerous international affiliations and accreditations.

https://ewacademy.eu 

Photo - https://mma.prnewswire.com/media/1553916/All_participants_3.jpg  
Logo - https://mma.prnewswire.com/media/1538499/EWBG_EN_COLOR_Logo.jpg  

Modal title

Also from this source

Prof. Mike Chan's Precision Medicine Vision Validated by Landmark Human Cytology Study Mapping Over 400 Distinct Cell Types - with Special Focus on the Brain

Prof. Mike Chan's Precision Medicine Vision Validated by Landmark Human Cytology Study Mapping Over 400 Distinct Cell Types - with Special Focus on the Brain

A groundbreaking international study has mapped over 400 distinct human cell types, providing powerful validation for Prof. Mike Chan's longstanding...

European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan

European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan

European Wellness Biomedical Group (EWBG) has launched a new research initiative focused on Klotho, a protein with transformative potential in...

المزيد من الإصدارات من هذا المصدر

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Education

Education

Contracts

Contracts

المزيد من البيانات الصحفية في مواضيع ذات صلة

Contact PR Newswire

  • +971 (0) 4 368 1644
    from 8 AM - 5:30 PM GMT

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+971 (0) 4 368 1644
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.